Wikidata

(Q84171271)

English

Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution

scientific article published on 15 May 2012

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22609040
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22609040%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q84171271&oldid=1903419960"